What is HYPERFINE's earnings per share (EPS)?

HYPERFINE (HYPR) reported diluted earnings per share of $-0.43 for fiscal year 2025. This represents a 23.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

HYPERFINE Financials

HYPR

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows HYPERFINE (HYPR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HYPR FY2025 2026-05-12

Improving gross economics are being offset by a development-stage expense base that still relies on outside funding.

From FY2023 to FY2025, gross margin improved from 43.1% to 49.8%, showing the product is no longer being sold at a loss. Yet FY2025 R&D spend of $17.5M still exceeded revenue of $13.6M, which helps explain why lower burn has not translated into self-funded operations.

FY2025 operating cash outflow of -$27.9M was smaller than the -$35.6M net loss, so reported earnings were not being flattered by non-cash accounting. Because capital spending was just $1.2M, the gap between operating cash flow and free cash flow stayed narrow, making this an expense-funded rather than equipment-funded burn story.

The balance sheet still looks liquid on the surface, with $35.1M of cash and a 4.3x current ratio, so near-term bills are not the immediate constraint. But financing inflow of $27.5M in FY2025 nearly matched free cash burn of -$29.1M, showing that recent balance-sheet stability came from new capital rather than from the business funding itself.

Financial Health Signals

Financial Profile 40/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of HYPERFINE's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

HYPERFINE has an operating margin of -273.4%, meaning the company retains $-273 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -335.3% the prior year.

Growth

HYPERFINE's revenue grew 5.2% year-over-year to $13.6M, a solid pace of expansion. This earns a growth score of 51/100.

Leverage

100

HYPERFINE carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 4.34, HYPERFINE holds $4.34 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 86/100.

Cash Flow

While HYPERFINE generated -$27.9M in operating cash flow, capex of $1.2M consumed most of it, leaving -$29.1M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

HYPERFINE generates a -86.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -83.0% the prior year.

Piotroski F-Score Neutral

4/9

HYPERFINE passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality

0.79x

For every $1 of reported earnings, HYPERFINE generates $0.79 in operating cash flow (-$27.9M OCF vs -$35.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$13.6M

YoY+5.2%

5Y CAGR+115.2%

HYPERFINE generated $13.6M in revenue in fiscal year 2025. This represents an increase of 5.2% from the prior year.

EBITDA

-$36.0M

YoY+14.7%

HYPERFINE's EBITDA was -$36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 14.7% from the prior year.

Net Income

-$35.6M

YoY+12.6%

HYPERFINE reported -$35.6M in net income in fiscal year 2025. This represents an increase of 12.6% from the prior year.

EPS (Diluted)

$-0.43

YoY+23.2%

HYPERFINE earned $-0.43 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$29.1M

YoY+25.6%

HYPERFINE generated -$29.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 25.6% from the prior year.

Cash & Debt

$35.1M

YoY-6.8%

5Y CAGR-11.0%

HYPERFINE held $35.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

49.8%

YoY+4.1pp

5Y CAGR+212.0pp

HYPERFINE's gross margin was 49.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.1 percentage points from the prior year.

Operating Margin

-273.4%

YoY+61.9pp

5Y CAGR+7716.7pp

HYPERFINE's operating margin was -273.4% in fiscal year 2025, reflecting core business profitability. This is up 61.9 percentage points from the prior year.

Net Margin

-262.3%

YoY+53.6pp

5Y CAGR+7706.1pp

HYPERFINE's net profit margin was -262.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 53.6 percentage points from the prior year.

Return on Equity

-86.8%

YoY-3.7pp

HYPERFINE's ROE was -86.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$17.5M

YoY-22.4%

5Y CAGR+3.6%

HYPERFINE invested $17.5M in research and development in fiscal year 2025. This represents a decrease of 22.4% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$1.2M

YoY+209.4%

5Y CAGR-5.4%

HYPERFINE invested $1.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 209.4% from the prior year.

HYPR Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$13.6M+5.2%	$12.9M+16.8%	$11.0M+61.9%	$6.8M+355.5%	$1.5M+408.8%	$294K
Cost of Revenue	$6.8M-2.7%	$7.0M+11.5%	$6.3M+6.2%	$5.9M+121.8%	$2.7M+245.4%	$771K
Gross Profit	$6.8M+14.6%	$5.9M+23.8%	$4.8M+424.5%	$907K+177.7%	-$1.2M-144.7%	-$477K
R&D Expenses	$17.5M-22.4%	$22.5M0.0%	$22.5M-20.1%	$28.2M+9.0%	$25.8M+77.1%	$14.6M
SG&A Expenses	$16.3M-7.1%	$17.5M-13.7%	$20.3M-37.4%	$32.4M+17.9%	$27.5M+364.4%	$5.9M
Operating Income	-$37.1M+14.2%	-$43.2M+10.2%	-$48.1M+34.9%	-$73.9M-13.9%	-$64.9M-176.1%	-$23.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	N/A
Net Income	-$35.6M+12.6%	-$40.7M+8.0%	-$44.2M0.0%	-$44.2M+31.8%	-$64.9M-176.8%	-$23.4M
EPS (Diluted)	$-0.43+23.2%	$-0.56+9.7%	$-0.62+40.4%	$-1.04+94.1%	$-17.57	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$3.9M-26.3%	$5.3M+54.0%	$3.4M+27.5%	$2.7M+26.2%	$2.1M-7.9%	$2.3M-36.3%	$3.6M+0.3%	$3.6M
Cost of Revenue	$1.9M-26.0%	$2.6M+63.6%	$1.6M+16.2%	$1.4M+9.1%	$1.3M-16.1%	$1.5M-13.8%	$1.7M-5.1%	$1.8M
Gross Profit	$2.0M-26.5%	$2.7M+45.8%	$1.8M+39.2%	$1.3M+50.4%	$883K+6.9%	$826K-56.7%	$1.9M+5.8%	$1.8M
R&D Expenses	$3.8M+0.5%	$3.8M-5.5%	$4.0M-10.9%	$4.5M-9.8%	$5.0M-1.3%	$5.1M-13.0%	$5.9M-1.6%	$6.0M
SG&A Expenses	$4.1M+2.4%	$4.0M-2.8%	$4.2M+7.6%	$3.9M-8.3%	$4.2M+1.8%	$4.1M-8.4%	$4.5M+2.0%	$4.4M
Operating Income	-$8.6M-11.6%	-$7.7M+14.0%	-$8.9M+7.0%	-$9.6M+12.0%	-$10.9M-1.3%	-$10.8M+1.8%	-$11.0M-1.1%	-$10.8M
Interest Expense	$83K	N/A	N/A	N/A	$0	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$8.6M-45.9%	-$5.9M+46.3%	-$11.0M-19.4%	-$9.2M+2.0%	-$9.4M+9.4%	-$10.4M-0.6%	-$10.3M-1.7%	-$10.2M
EPS (Diluted)	$-0.09	N/A	$-0.14-16.7%	$-0.120.0%	$-0.12	N/A	$-0.140.0%	$-0.14

HYPR Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$55.3M-6.2%	$58.9M-37.5%	$94.2M-29.7%	$134.1M-33.8%	$202.5M+183.1%	$71.5M
Current Assets	$50.9M-5.2%	$53.7M-39.6%	$88.9M-30.9%	$128.7M-34.8%	$197.5M+189.0%	$68.3M
Cash & Equivalents	$35.1M-6.8%	$37.6M-49.9%	$75.2M-36.0%	$117.5M-37.7%	$188.5M+200.7%	$62.7M
Inventory	$7.1M+21.6%	$5.8M-11.4%	$6.6M+42.4%	$4.6M+7.2%	$4.3M+150.9%	$1.7M
Accounts Receivable	$5.3M-11.8%	$6.0M+86.8%	$3.2M+51.6%	$2.1M+280.3%	$553K+217.8%	$174K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$14.3M+44.6%	$9.9M+0.6%	$9.8M-5.1%	$10.3M-36.4%	$16.2M-87.7%	$132.6M
Current Liabilities	$11.7M+34.4%	$8.7M-0.4%	$8.8M-0.4%	$8.8M-44.1%	$15.7M+282.3%	$4.1M
Long-Term Debt	$0	N/A	N/A	N/A	N/A	N/A
Total Equity	$41.0M-16.4%	$49.0M-41.9%	$84.4M-31.8%	$123.7M-33.6%	$186.2M+405.0%	-$61.1M
Retained Earnings	-$330.0M-12.1%	-$294.4M-16.0%	-$253.7M-21.1%	-$209.5M-53.7%	-$136.3M-90.7%	-$71.5M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$60.3M+9.2%	$55.3M+33.1%	$41.5M-8.2%	$45.2M-15.3%	$53.4M-9.4%	$58.9M-15.1%	$69.4M-9.4%	$76.6M
Current Assets	$56.0M+10.1%	$50.9M+38.0%	$36.9M-8.0%	$40.1M-17.2%	$48.4M-9.9%	$53.7M-16.2%	$64.1M-9.8%	$71.0M
Cash & Equivalents	$40.8M+16.2%	$35.1M+62.7%	$21.6M-15.2%	$25.4M-23.2%	$33.1M-12.1%	$37.6M-17.7%	$45.8M-14.9%	$53.8M
Inventory	$6.3M-10.8%	$7.1M+21.4%	$5.8M+19.6%	$4.9M+5.2%	$4.6M-20.5%	$5.8M-17.2%	$7.0M-5.6%	$7.5M
Accounts Receivable	$3.8M-27.8%	$5.3M+7.5%	$4.9M-3.4%	$5.1M-5.1%	$5.3M-10.5%	$6.0M-12.4%	$6.8M+26.7%	$5.4M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$26.0M+82.2%	$14.3M-2.6%	$14.6M+44.8%	$10.1M-1.5%	$10.3M+4.1%	$9.9M-10.9%	$11.1M+12.3%	$9.8M
Current Liabilities	$10.2M-13.5%	$11.7M+15.4%	$10.2M+27.3%	$8.0M+0.1%	$8.0M-8.6%	$8.7M-12.4%	$10.0M+13.4%	$8.8M
Long-Term Debt	$13.1M	$0	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$34.4M-16.2%	$41.0M+52.6%	$26.9M-23.5%	$35.1M-18.5%	$43.1M-12.1%	$49.0M-15.9%	$58.3M-12.6%	$66.8M
Retained Earnings	-$338.6M-2.6%	-$330.0M-1.8%	-$324.1M-3.5%	-$313.1M-3.0%	-$303.9M-3.2%	-$294.4M-3.7%	-$284.1M-3.8%	-$273.7M

HYPR Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$27.9M+27.9%	-$38.8M+7.3%	-$41.8M+42.2%	-$72.3M-53.3%	-$47.2M-119.2%	-$21.5M
Capital Expenditures	$1.2M+209.4%	$383K-52.4%	$804K+37.4%	$585K-78.4%	$2.7M+72.9%	$1.6M
Free Cash Flow	-$29.1M+25.6%	-$39.1M+8.1%	-$42.6M+41.6%	-$72.9M-46.2%	-$49.9M-116.1%	-$23.1M
Investing Cash Flow	-$1.2M-209.4%	-$383K+52.4%	-$804K-37.4%	-$585K+78.4%	-$2.7M-72.9%	-$1.6M
Financing Cash Flow	$27.5M+2598.9%	$1.0M+485.6%	$174K+2385.7%	$7K-100.0%	$176.8M+190.1%	$60.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$9.0M-73.0%	-$5.2M+6.7%	-$5.6M+29.4%	-$7.9M+14.5%	-$9.2M-10.7%	-$8.4M+1.9%	-$8.5M+9.2%	-$9.4M
Capital Expenditures	$242K+284.1%	$63K-51.5%	$130K-75.0%	$520K+10.2%	$472K+5800.0%	$8K-95.0%	$159K+123.9%	$71K
Free Cash Flow	-$9.3M-75.5%	-$5.3M+7.7%	-$5.7M+32.2%	-$8.4M+13.3%	-$9.7M-16.2%	-$8.4M+3.6%	-$8.7M+8.2%	-$9.5M
Investing Cash Flow	-$242K-284.1%	-$63K+51.5%	-$130K+75.0%	-$520K-10.2%	-$472K-5800.0%	-$8K+95.0%	-$159K-123.9%	-$71K
Financing Cash Flow	$14.5M-24.9%	$19.3M+791.0%	$2.2M+356.5%	$474K-91.5%	$5.6M+10237.0%	$54K-93.7%	$851K+1342.4%	$59K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HYPR Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	49.8%+4.1pp	45.7%+2.6pp	43.1%+29.8pp	13.3%+91.3pp	-78.0%+84.2pp	-162.2%
Operating Margin	-273.4%+61.9pp	-335.3%+100.8pp	-436.1%+648.0pp	-1084.2%+3251.9pp	-4336.1%+3654.0pp	-7990.1%
Net Margin	-262.3%+53.6pp	-315.9%+85.1pp	-401.0%+248.2pp	-649.2%+3685.7pp	-4335.0%+3633.4pp	-7968.4%
Return on Equity	-86.8%-3.7pp	-83.0%-30.6pp	-52.4%-16.7pp	-35.8%-0.9pp	-34.8%	N/A
Return on Assets	-64.4%+4.8pp	-69.1%-22.2pp	-47.0%-14.0pp	-33.0%-1.0pp	-32.0%+0.7pp	-32.8%
Current Ratio	4.34-1.8	6.15-4.0	10.14-4.5	14.62+2.1	12.55-4.1	16.60
Debt-to-Equity	0.00-0.2	0.20+0.1	0.12+0.0	0.080.0	0.09+2.3	-2.17
FCF Margin	-214.8%+88.9pp	-303.7%+82.5pp	-386.3%+683.9pp	-1070.2%+2264.9pp	-3335.1%+4519.7pp	-7854.8%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	50.7%-0.2pp	50.9%-2.9pp	53.8%+4.5pp	49.3%+7.9pp	41.3%+5.7pp	35.6%-16.8pp	52.4%+2.7pp	49.7%
Operating Margin	-219.3%-74.4pp	-144.9%+114.7pp	-259.5%+96.4pp	-355.9%+154.2pp	-510.1%-46.3pp	-463.8%-162.9pp	-300.9%-2.2pp	-298.7%
Net Margin	-220.9%-109.2pp	-111.7%+208.9pp	-320.6%+21.6pp	-342.2%+98.5pp	-440.7%+6.9pp	-447.6%-164.2pp	-283.4%-3.7pp	-279.7%
Return on Equity	-25.1%-10.7pp	-14.4%+26.6pp	-41.0%-14.8pp	-26.3%-4.4pp	-21.8%-0.7pp	-21.2%-3.5pp	-17.7%-2.5pp	-15.2%
Return on Assets	-14.3%-3.6pp	-10.7%+15.8pp	-26.5%-6.2pp	-20.4%-2.7pp	-17.6%0.0pp	-17.6%-2.8pp	-14.9%-1.6pp	-13.3%
Current Ratio	5.52+1.2	4.34+0.7	3.63-1.4	5.02-1.0	6.07-0.1	6.15-0.3	6.44-1.6	8.08
Debt-to-Equity	0.38+0.4	0.00-0.5	0.54+0.3	0.29+0.0	0.24+0.0	0.20+0.0	0.19+0.0	0.15
FCF Margin	-237.0%-137.4pp	-99.6%+66.6pp	-166.2%+146.5pp	-312.7%+142.2pp	-454.9%-94.5pp	-360.4%-122.2pp	-238.2%+22.2pp	-260.4%

Similar Companies

Icad Inc ICAD

$105.8M

Owlet Inc OWLT

$166.5M

Profound Med Corp PROF

$253.3M

Lucid Diagnostics Inc. LUCD

$190.8M

Inspiremd NSPR

$48.2M

Frequently Asked Questions

What is HYPERFINE's annual revenue?

HYPERFINE (HYPR) reported $13.6M in total revenue for fiscal year 2025. This represents a 5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is HYPERFINE's revenue growing?

HYPERFINE (HYPR) revenue grew by 5.2% year-over-year, from $12.9M to $13.6M in fiscal year 2025.

Is HYPERFINE profitable?

No, HYPERFINE (HYPR) reported a net income of -$35.6M in fiscal year 2025, with a net profit margin of -262.3%.

What is HYPERFINE's EBITDA?

HYPERFINE (HYPR) had EBITDA of -$36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does HYPERFINE have?

As of fiscal year 2025, HYPERFINE (HYPR) had $35.1M in cash and equivalents against $0 in long-term debt.

What is HYPERFINE's gross margin?

HYPERFINE (HYPR) had a gross margin of 49.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is HYPERFINE's operating margin?

HYPERFINE (HYPR) had an operating margin of -273.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is HYPERFINE's net profit margin?

HYPERFINE (HYPR) had a net profit margin of -262.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is HYPERFINE's return on equity (ROE)?

HYPERFINE (HYPR) has a return on equity of -86.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is HYPERFINE's free cash flow?

HYPERFINE (HYPR) generated -$29.1M in free cash flow during fiscal year 2025. This represents a 25.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is HYPERFINE's operating cash flow?

HYPERFINE (HYPR) generated -$27.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are HYPERFINE's total assets?

HYPERFINE (HYPR) had $55.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are HYPERFINE's capital expenditures?

HYPERFINE (HYPR) invested $1.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does HYPERFINE spend on research and development?

HYPERFINE (HYPR) invested $17.5M in research and development during fiscal year 2025.

What is HYPERFINE's current ratio?

HYPERFINE (HYPR) had a current ratio of 4.34 as of fiscal year 2025, which is generally considered healthy.

What is HYPERFINE's debt-to-equity ratio?

HYPERFINE (HYPR) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is HYPERFINE's return on assets (ROA)?

HYPERFINE (HYPR) had a return on assets of -64.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is HYPERFINE's cash runway?

Based on fiscal year 2025 data, HYPERFINE (HYPR) had $35.1M in cash against an annual operating cash burn of $27.9M. This gives an estimated cash runway of approximately 15 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is HYPERFINE's Piotroski F-Score?

HYPERFINE (HYPR) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are HYPERFINE's earnings high quality?

HYPERFINE (HYPR) has an earnings quality ratio of 0.79x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is HYPERFINE?

HYPERFINE (HYPR) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.